Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Mar;1(2):189–196. doi: 10.1128/cdli.1.2.189-196.1994

Q fever serology: cutoff determination for microimmunofluorescence.

H T Dupont 1, X Thirion 1, D Raoult 1
PMCID: PMC368226  PMID: 7496944

Abstract

Q fever, a worldwide zoonosis caused by Coxiella burnetii, lacks clinical specificity and may present as acute or chronic disease. Because of this polymorphism, serological confirmation is necessary to assess the diagnosis. Although microimmunofluorescence is our reference technique, the cutoff titers that are currently used to make a diagnosis of active or chronic Q fever were determined years ago with limited series of patients and sera. We determined the titers of immunoglobulin G (IgG), IgM, and IgA against both phases (I and II) of Coxiella burnetii. Rheumatoid factor was removed before testing IgM and IgA. We report here the various cutoff titers and the kinetics of antibody development from 2,218 first serum samples of patients, among whom 208 suffered from acute Q fever and 53 had chronic Q fever. In active Q fever, we have defined a low cutoff (phase II IgG titer < or = 100) below which the diagnosis cannot be made and would need further confirmation and confirmed a high cutoff (phase II IgG titer > or = 200 and phase II IgM titer > or = 50) over which the diagnosis can be made. For chronic Q fever diagnosis, phase I IgA titers are not contributive despite previous works claiming their usefulness; a phase I IgG titer of > or = 800 is highly predictive (98%) and sensitive (100%). We have also studied the possibility of rejecting or evoking the diagnosis of chronic Q fever by phase II IgG and IgA titers. This method is useful when phase I testing is not available, but the sensitivity remains low (57%).

Full text

PDF
189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brouqui P., Dupont H. T., Drancourt M., Berland Y., Etienne J., Leport C., Goldstein F., Massip P., Micoud M., Bertrand A. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med. 1993 Mar 8;153(5):642–648. doi: 10.1001/archinte.153.5.642. [DOI] [PubMed] [Google Scholar]
  2. Dupuis G., Péter O., Peacock M., Burgdorfer W., Haller E. Immunoglobulin responses in acute Q fever. J Clin Microbiol. 1985 Oct;22(4):484–487. doi: 10.1128/jcm.22.4.484-487.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Edlinger E. Immunofluorescence serology. A tool for prognosis of Q-fever. Diagn Microbiol Infect Dis. 1985 Jul;3(4):343–351. doi: 10.1016/0732-8893(85)90009-4. [DOI] [PubMed] [Google Scholar]
  4. Fergusson R. J., Shaw T. R., Kitchin A. H., Matthews M. B., Inglis J. M., Peutherer J. F. Subclinical chronic Q fever. Q J Med. 1985 Oct;57(222):669–676. [PubMed] [Google Scholar]
  5. Field P. R., Hunt J. G., Murphy A. M. Detection and persistence of specific IgM antibody to Coxiella burnetii by enzyme-linked immunosorbent assay: a comparison with immunofluorescence and complement fixation tests. J Infect Dis. 1983 Sep;148(3):477–487. doi: 10.1093/infdis/148.3.477. [DOI] [PubMed] [Google Scholar]
  6. Finidori J. P., Raoult D., Bornstein N., Fleurette J. Study of cross-reaction between Coxiella burnetii and Legionella pneumophila using indirect immunofluorescence assay and immunoblotting. Acta Virol. 1992 Oct;36(5):459–465. [PubMed] [Google Scholar]
  7. GIMENEZ D. F. STAINING RICKETTSIAE IN YOLK-SAC CULTURES. Stain Technol. 1964 May;39:135–140. doi: 10.3109/10520296409061219. [DOI] [PubMed] [Google Scholar]
  8. Guigno D., Coupland B., Smith E. G., Farrell I. D., Desselberger U., Caul E. O. Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever. J Clin Microbiol. 1992 Aug;30(8):1958–1967. doi: 10.1128/jcm.30.8.1958-1967.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hunt J. G., Field P. R., Murphy A. M. Immunoglobulin responses to Coxiella burnetii (Q fever): single-serum diagnosis of acute infection, using an immunofluorescence technique. Infect Immun. 1983 Feb;39(2):977–981. doi: 10.1128/iai.39.2.977-981.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Peacock M. G., Philip R. N., Williams J. C., Faulkner R. S. Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun. 1983 Sep;41(3):1089–1098. doi: 10.1128/iai.41.3.1089-1098.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Raoult D., Etienne J., Massip P., Iaocono S., Prince M. A., Beaurain P., Benichou S., Auvergnat J. C., Mathieu P., Bachet P. Q fever endocarditis in the south of France. J Infect Dis. 1987 Mar;155(3):570–573. doi: 10.1093/infdis/155.3.570. [DOI] [PubMed] [Google Scholar]
  12. Raoult D., Levy P. Y., Harlé J. R., Etienne J., Massip P., Goldstein F., Micoud M., Beytout J., Gallais H., Remy G. Chronic Q fever: diagnosis and follow-up. Ann N Y Acad Sci. 1990;590:51–60. doi: 10.1111/j.1749-6632.1990.tb42206.x. [DOI] [PubMed] [Google Scholar]
  13. Raoult D., Urvölgyi J., Etienne J., Roturier M., Puel J., Chaudet H. Diagnosis of endocarditis in acute Q-fever by immunofluorescence serology. Acta Virol. 1988 Jan;32(1):70–74. [PubMed] [Google Scholar]
  14. STOKER M. G., FISET P. Phase variation of the Nine Mile and other strains of Rickettsia burneti. Can J Microbiol. 1956 May;2(3):310–321. doi: 10.1139/m56-036. [DOI] [PubMed] [Google Scholar]
  15. Williams J. C., Johnston M. R., Peacock M. G., Thomas L. A., Stewart S., Portis J. L. Monoclonal antibodies distinguish phase variants of Coxiella burnetii. Infect Immun. 1984 Jan;43(1):421–428. doi: 10.1128/iai.43.1.421-428.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Worswick D., Marmion B. P. Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever. J Med Microbiol. 1985 Jun;19(3):281–296. doi: 10.1099/00222615-19-3-281. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES